NO901894L - PROCEDURE FOR THE PREPARATION OF SUBSTITUTED BIFENYL CARBOXYL ACIDS AND NEW INTERMEDIATES. - Google Patents
PROCEDURE FOR THE PREPARATION OF SUBSTITUTED BIFENYL CARBOXYL ACIDS AND NEW INTERMEDIATES.Info
- Publication number
- NO901894L NO901894L NO90901894A NO901894A NO901894L NO 901894 L NO901894 L NO 901894L NO 90901894 A NO90901894 A NO 90901894A NO 901894 A NO901894 A NO 901894A NO 901894 L NO901894 L NO 901894L
- Authority
- NO
- Norway
- Prior art keywords
- formula
- acid
- indicated
- meaning
- iii
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 17
- 239000002253 acid Substances 0.000 title claims description 6
- 238000002360 preparation method Methods 0.000 title description 6
- 239000000543 intermediate Substances 0.000 title description 4
- -1 CARBOXYL ACIDS Chemical class 0.000 title description 2
- ZABMHLDQFJHDSC-UHFFFAOYSA-N 2,3-dihydro-1,3-oxazole Chemical compound C1NC=CO1 ZABMHLDQFJHDSC-UHFFFAOYSA-N 0.000 claims description 16
- ILYSAKHOYBPSPC-UHFFFAOYSA-N 2-phenylbenzoic acid Chemical compound OC(=O)C1=CC=CC=C1C1=CC=CC=C1 ILYSAKHOYBPSPC-UHFFFAOYSA-N 0.000 claims description 13
- 150000001875 compounds Chemical class 0.000 claims description 11
- 150000001408 amides Chemical class 0.000 claims description 10
- 238000004519 manufacturing process Methods 0.000 claims description 7
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 6
- 239000001257 hydrogen Substances 0.000 claims description 6
- 229910052739 hydrogen Inorganic materials 0.000 claims description 6
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 5
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical class C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 claims description 5
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims description 4
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 claims description 4
- ILUJQPXNXACGAN-UHFFFAOYSA-N O-methylsalicylic acid Chemical compound COC1=CC=CC=C1C(O)=O ILUJQPXNXACGAN-UHFFFAOYSA-N 0.000 claims description 4
- 239000003153 chemical reaction reagent Substances 0.000 claims description 4
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 4
- 125000002524 organometallic group Chemical group 0.000 claims description 4
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 claims description 3
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 claims description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 2
- KIWBPDUYBMNFTB-UHFFFAOYSA-N Ethyl hydrogen sulfate Chemical compound CCOS(O)(=O)=O KIWBPDUYBMNFTB-UHFFFAOYSA-N 0.000 claims description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 2
- 229910052794 bromium Inorganic materials 0.000 claims description 2
- 239000000460 chlorine Substances 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 2
- 229910052744 lithium Inorganic materials 0.000 claims description 2
- JZMJDSHXVKJFKW-UHFFFAOYSA-M methyl sulfate(1-) Chemical compound COS([O-])(=O)=O JZMJDSHXVKJFKW-UHFFFAOYSA-M 0.000 claims description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 30
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 30
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 21
- 238000006243 chemical reaction Methods 0.000 description 20
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 17
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 14
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 14
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 13
- VEOGWHFDYPRACH-UHFFFAOYSA-N 2,7-difluorofluoren-9-one Chemical compound C1=C(F)C=C2C(=O)C3=CC(F)=CC=C3C2=C1 VEOGWHFDYPRACH-UHFFFAOYSA-N 0.000 description 12
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 10
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 10
- 235000011121 sodium hydroxide Nutrition 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 9
- 239000000047 product Substances 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 7
- 238000001816 cooling Methods 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 6
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 5
- JRBIZCAGWPOVKV-UHFFFAOYSA-M 2-[5-fluoro-2-(4-fluorophenyl)phenyl]-3,4,4-trimethyl-5h-1,3-oxazol-3-ium;methyl sulfate Chemical compound COS([O-])(=O)=O.O1CC(C)(C)[N+](C)=C1C1=CC(F)=CC=C1C1=CC=C(F)C=C1 JRBIZCAGWPOVKV-UHFFFAOYSA-M 0.000 description 5
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 5
- 150000001414 amino alcohols Chemical class 0.000 description 5
- 238000004821 distillation Methods 0.000 description 5
- 238000007710 freezing Methods 0.000 description 5
- 230000008014 freezing Effects 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000012071 phase Substances 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- 238000005160 1H NMR spectroscopy Methods 0.000 description 4
- QCCHBHSAIQIQGO-UHFFFAOYSA-N 2,7-difluorospiro[fluorene-9,5'-imidazolidine]-2',4'-dione Chemical compound C12=CC(F)=CC=C2C2=CC=C(F)C=C2C21NC(=O)NC2=O QCCHBHSAIQIQGO-UHFFFAOYSA-N 0.000 description 4
- CHQPXZPHDTZKPT-UHFFFAOYSA-N 5-fluoro-2-(4-fluorophenyl)benzoic acid Chemical compound OC(=O)C1=CC(F)=CC=C1C1=CC=C(F)C=C1 CHQPXZPHDTZKPT-UHFFFAOYSA-N 0.000 description 4
- WPXFJBPJUGMYOD-UHFFFAOYSA-N 5-fluoro-2-methoxybenzoic acid Chemical compound COC1=CC=C(F)C=C1C(O)=O WPXFJBPJUGMYOD-UHFFFAOYSA-N 0.000 description 4
- 239000007818 Grignard reagent Substances 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- YLQWCDOCJODRMT-UHFFFAOYSA-N fluoren-9-one Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3C2=C1 YLQWCDOCJODRMT-UHFFFAOYSA-N 0.000 description 4
- 229910052731 fluorine Inorganic materials 0.000 description 4
- 150000004795 grignard reagents Chemical class 0.000 description 4
- 238000006396 nitration reaction Methods 0.000 description 4
- 239000012074 organic phase Substances 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- 238000007363 ring formation reaction Methods 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- AITNMTXHTIIIBB-UHFFFAOYSA-N 1-bromo-4-fluorobenzene Chemical compound FC1=CC=C(Br)C=C1 AITNMTXHTIIIBB-UHFFFAOYSA-N 0.000 description 3
- ZHCAVDOOLQJCQR-UHFFFAOYSA-N 2-[5-fluoro-2-(4-fluorophenyl)phenyl]-4,4-dimethyl-5h-1,3-oxazole Chemical compound CC1(C)COC(C=2C(=CC=C(F)C=2)C=2C=CC(F)=CC=2)=N1 ZHCAVDOOLQJCQR-UHFFFAOYSA-N 0.000 description 3
- SNCJAJRILVFXAE-UHFFFAOYSA-N 9h-fluorene-2,7-diamine Chemical compound NC1=CC=C2C3=CC=C(N)C=C3CC2=C1 SNCJAJRILVFXAE-UHFFFAOYSA-N 0.000 description 3
- 239000005711 Benzoic acid Substances 0.000 description 3
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 3
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- 235000010233 benzoic acid Nutrition 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 230000000711 cancerogenic effect Effects 0.000 description 3
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 3
- 239000011737 fluorine Substances 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 239000000155 melt Substances 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 229920000137 polyphosphoric acid Polymers 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 238000001953 recrystallisation Methods 0.000 description 3
- 229910052938 sodium sulfate Inorganic materials 0.000 description 3
- 235000011152 sodium sulphate Nutrition 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- BNDBYDSPAZGULI-UHFFFAOYSA-N 2,7-difluoro-9h-fluorene Chemical compound FC1=CC=C2C3=CC=C(F)C=C3CC2=C1 BNDBYDSPAZGULI-UHFFFAOYSA-N 0.000 description 2
- ALCCHQWETCASQJ-UHFFFAOYSA-N 2,7-difluorofluoren-1-one Chemical compound FC1=CC=C2C3=CC=C(F)C(=O)C3=CC2=C1 ALCCHQWETCASQJ-UHFFFAOYSA-N 0.000 description 2
- RILZRCJGXSFXNE-UHFFFAOYSA-N 2-[4-(trifluoromethoxy)phenyl]ethanol Chemical compound OCCC1=CC=C(OC(F)(F)F)C=C1 RILZRCJGXSFXNE-UHFFFAOYSA-N 0.000 description 2
- 229940058020 2-amino-2-methyl-1-propanol Drugs 0.000 description 2
- FCSKOFQQCWLGMV-UHFFFAOYSA-N 5-{5-[2-chloro-4-(4,5-dihydro-1,3-oxazol-2-yl)phenoxy]pentyl}-3-methylisoxazole Chemical compound O1N=C(C)C=C1CCCCCOC1=CC=C(C=2OCCN=2)C=C1Cl FCSKOFQQCWLGMV-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical class [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000002168 alkylating agent Substances 0.000 description 2
- 229940100198 alkylating agent Drugs 0.000 description 2
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- GZUXJHMPEANEGY-UHFFFAOYSA-N bromomethane Chemical compound BrC GZUXJHMPEANEGY-UHFFFAOYSA-N 0.000 description 2
- 231100000315 carcinogenic Toxicity 0.000 description 2
- NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical compound ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 238000006193 diazotization reaction Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 239000012442 inert solvent Substances 0.000 description 2
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 229940098779 methanesulfonic acid Drugs 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 238000006798 ring closing metathesis reaction Methods 0.000 description 2
- 238000007127 saponification reaction Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 125000006526 (C1-C2) alkyl group Chemical group 0.000 description 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
- BEFAQJJPFPNXIG-UHFFFAOYSA-N 1-nitro-9h-fluorene Chemical class C1C2=CC=CC=C2C2=C1C([N+](=O)[O-])=CC=C2 BEFAQJJPFPNXIG-UHFFFAOYSA-N 0.000 description 1
- OFJBYLCQNJHFMI-UHFFFAOYSA-N 2,5-dihydro-1,2-oxazole Chemical compound C1ONC=C1 OFJBYLCQNJHFMI-UHFFFAOYSA-N 0.000 description 1
- MNPQZHCMHFVPDN-UHFFFAOYSA-N 2,7-difluoro-4-methoxyfluoren-9-one Chemical class O=C1C2=CC(F)=CC=C2C2=C1C=C(F)C=C2OC MNPQZHCMHFVPDN-UHFFFAOYSA-N 0.000 description 1
- IHZCVUBSTYOFSJ-UHFFFAOYSA-N 2,7-dinitro-9h-fluorene Chemical compound [O-][N+](=O)C1=CC=C2C3=CC=C([N+](=O)[O-])C=C3CC2=C1 IHZCVUBSTYOFSJ-UHFFFAOYSA-N 0.000 description 1
- YSAAQOKKESIFLM-UHFFFAOYSA-N 2-(5-fluoro-2-methoxyphenyl)-4,4-dimethyl-5h-1,3-oxazole Chemical compound COC1=CC=C(F)C=C1C1=NC(C)(C)CO1 YSAAQOKKESIFLM-UHFFFAOYSA-N 0.000 description 1
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 1
- SXHKHHXFAQRZOI-UHFFFAOYSA-N 2-fluorofluoren-1-one Chemical compound C1=CC=C2C3=CC=C(F)C(=O)C3=CC2=C1 SXHKHHXFAQRZOI-UHFFFAOYSA-N 0.000 description 1
- JHWIEAWILPSRMU-UHFFFAOYSA-N 2-methyl-3-pyrimidin-4-ylpropanoic acid Chemical compound OC(=O)C(C)CC1=CC=NC=N1 JHWIEAWILPSRMU-UHFFFAOYSA-N 0.000 description 1
- CYSPWCARDHRYJX-UHFFFAOYSA-N 9h-fluoren-1-amine Chemical class C12=CC=CC=C2CC2=C1C=CC=C2N CYSPWCARDHRYJX-UHFFFAOYSA-N 0.000 description 1
- 229910014033 C-OH Inorganic materials 0.000 description 1
- 229910014570 C—OH Inorganic materials 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- 238000003747 Grignard reaction Methods 0.000 description 1
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 238000006350 Schiemann fluorination reaction Methods 0.000 description 1
- 208000021945 Tendon injury Diseases 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910001854 alkali hydroxide Inorganic materials 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 239000011260 aqueous acid Substances 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- FZFAMSAMCHXGEF-UHFFFAOYSA-N chloro formate Chemical compound ClOC=O FZFAMSAMCHXGEF-UHFFFAOYSA-N 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000012954 diazonium Substances 0.000 description 1
- YWEUIGNSBFLMFL-UHFFFAOYSA-N diphosphonate Chemical compound O=P(=O)OP(=O)=O YWEUIGNSBFLMFL-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 150000008376 fluorenones Chemical class 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 229950007327 imirestat Drugs 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 229940102396 methyl bromide Drugs 0.000 description 1
- 229940050176 methyl chloride Drugs 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 229910017464 nitrogen compound Inorganic materials 0.000 description 1
- 150000002830 nitrogen compounds Chemical class 0.000 description 1
- 238000010534 nucleophilic substitution reaction Methods 0.000 description 1
- 150000002941 palladium compounds Chemical class 0.000 description 1
- UQPUONNXJVWHRM-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 UQPUONNXJVWHRM-UHFFFAOYSA-N 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 239000003444 phase transfer catalyst Substances 0.000 description 1
- DLYUQMMRRRQYAE-UHFFFAOYSA-N phosphorus pentoxide Inorganic materials O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- QLNJFJADRCOGBJ-UHFFFAOYSA-N propionamide Chemical compound CCC(N)=O QLNJFJADRCOGBJ-UHFFFAOYSA-N 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- BBDNZMUIQBRBJH-UHFFFAOYSA-N sulfurochloridic acid;toluene Chemical compound OS(Cl)(=O)=O.CC1=CC=CC=C1 BBDNZMUIQBRBJH-UHFFFAOYSA-N 0.000 description 1
- ZXUCBXRTRRIBSO-UHFFFAOYSA-L tetrabutylazanium;sulfate Chemical compound [O-]S([O-])(=O)=O.CCCC[N+](CCCC)(CCCC)CCCC.CCCC[N+](CCCC)(CCCC)CCCC ZXUCBXRTRRIBSO-UHFFFAOYSA-L 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 150000003752 zinc compounds Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C63/00—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
- C07C63/04—Monocyclic monocarboxylic acids
- C07C63/06—Benzoic acid
- C07C63/10—Halides thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C63/00—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
- C07C63/68—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings containing halogen
- C07C63/72—Polycyclic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/21—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
- C07C65/24—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups polycyclic
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
Oppfinnelsen vedrører substituerte bifenylkarboksylsyrer med formel I The invention relates to substituted biphenylcarboxylic acids of formula I
der R<1>betyr hydrogen eller metoksy, såvel som fremgangsmåte for deres fremstilling. De substituerte bifenylkarboksylsyrene med formel I lar seg overføre ved cyklisering til de tilsvarende 2,7-difluor-fluorenon med formel IX where R<1> means hydrogen or methoxy, as well as methods for their preparation. The substituted biphenylcarboxylic acids of formula I can be transferred by cyclization to the corresponding 2,7-difluoro-fluorenone of formula IX
Fra disse lar de seg fremstille i et enkelt reaksjonstrinn 2,7-difluor-spiro[9H-fluoren-9,4 ' -imidazolidin] -2 ' , 5 ' -dion (også betegnet AL 1576, HOE 843 og Imirestat), h.h.v. 2,7-dif luor-4-metoksy-spiro-[9H-fluoren-9,4'-imidazolidin]-2,5' - dion, som kan bli anvendt som legemiddel til behandling av diabetes-senskader (sml. US-PS nr. 4.438.272). From these, they can be prepared in a single reaction step 2,7-difluoro-spiro[9H-fluorene-9,4'-imidazolidine]-2', 5'-dione (also designated AL 1576, HOE 843 and Imirestat), respectively 2,7-difluoro-4-methoxy-spiro-[9H-fluorene-9,4'-imidazolidine]-2,5'-dione, which can be used as a drug for the treatment of diabetic tendon injuries (cf. US- PS No. 4,438,272).
2,7-dif luorf luorenon som lett lar seg fremstille fra 4,4<*->difluorbifenyl-2-karboksylsyre lar seg fremstille etter dagens teknikk i en 9-trinns syntese fra fluoren, og nærmere bestemt ved nitrering i 2-stilling, reduksjon til amin, diazotering og Schiemann-reaksjon til 2-fluorfluorenon, deretter nitrering i 7-posisjon og fortsettelse med kjente reaksjonssekvenser til 2,7-difluorfluoren såvel som etter-følgende oksidering til 2,7-difluor-9-fluorenon IX med natriumdikromat (sml. f.eks. Chem. Ind. 1961, 179, J. Med. 2,7-difluorofluorenone, which can easily be prepared from 4,4<*->difluorobiphenyl-2-carboxylic acid, can be prepared according to current technology in a 9-step synthesis from fluorine, and more specifically by nitration in the 2-position, reduction to amine, diazotization and Schiemann reaction to 2-fluorofluorenone, then nitration in the 7-position and continuation with known reaction sequences to 2,7-difluorofluorene as well as subsequent oxidation to 2,7-difluoro-9-fluorenone IX with sodium dichromate (cf. e.g. Chem. Ind. 1961, 179, J. Med.
Chem. 8, 491 (1965), Isr. J. Chem. 1,1 (1963) og Chem. Ber. 112, 3490 (1979)). Chem. 8, 491 (1965), Isr. J. Chem. 1.1 (1963) and Chem. Pray. 112, 3490 (1979)).
Disse fremstillingsfremgangsmåtene består av flere trinn og det samlede utbytte ligger for tiden på 1056 på grunn av nødvendig isomeriadskillelse på nitrogenforbindelsestrinnet. These preparation methods consist of several steps and the overall yield is currently 1056 due to the necessary isomer separation at the nitrogen compound step.
En beskrevet fremgangsmåte i US-PS nr. 4.438.272 til fremstilling av 2,7-difluor-9-fluorenon utgår man fra 2,7-diaminofluoren, som blir overført ved behandling med fluor-borsyre til det tilsvarende saltet av fluorborsyren. Ved den etterfølgende diazoteringen kommer man til bis-diazoniumsalt, som under oppvarming i xylol frisetter 2,7-difluorfluoren. Oppoksideringen til 2,7-difluor-9-fluorenon foregår med KMn04i pyridin. A method described in US-PS No. 4,438,272 for the production of 2,7-difluoro-9-fluorenone starts from 2,7-diaminofluorene, which is converted by treatment with fluoroboric acid to the corresponding salt of the fluoroboric acid. The subsequent diazotization leads to the bis-diazonium salt, which releases 2,7-difluorofluorene when heated in xylol. The oxidation to 2,7-difluoro-9-fluorenone takes place with KMnO4i pyridine.
2,7-diaminofluoren som utgangsmateriale i denne syntesen er riktignok fremstilt ved nitrering av fluoren til 2,7-dinitro-fluoren og vanskelig etterfølgende reduksjon og i utilfreds-stillende utbytte, da det ved nitrering oppstår isomer-blandinger som må bli adskilt og at 2,7-diaminofluoren er meget lys- og oksidasjonsømfintlig. Det samlede utbytte basert på fluoren ligger også i denne fremgangsmåten bare ved ca. 10%. The 2,7-diaminofluorene as starting material in this synthesis is indeed produced by nitration of fluorine to 2,7-dinitro-fluorene and difficult subsequent reduction and in unsatisfactory yield, as isomer mixtures are formed during nitration which must be separated and that 2,7-diaminofluorene is very sensitive to light and oxidation. The overall yield based on the fluorine is also in this method only at approx. 10%.
En særlig alvorlig ulempe med de kjente syntesene av fluorenon med formel IX ligger hovedsakelig i at amino- og nitrofluorenderivater har kreftfremkallende egenskaper (sml. J. Nati. Cancer Inst. 10, 1201 (1950), Cancer. Res. 22, 1002 A particularly serious disadvantage of the known syntheses of fluorenone with formula IX lies mainly in the fact that amino and nitrofluorene derivatives have carcinogenic properties (cf. J. Nat. Cancer Inst. 10, 1201 (1950), Cancer. Res. 22, 1002
(1962), Brit. J. Cancer 4, 235 (1950), Brit. J. Exptl. Path. 25, 1 (1944) og Progressus Med. 3, 79 (1940)). (1962), Brit. J. Cancer 4, 235 (1950), Brit. J. Exptl. Path. 25, 1 (1944) and Progressus Med. 3, 79 (1940)).
Fremstilling av 2,7-difluor-4-metoksy-9-fluorenoner foregår via 4 h.h.v. 5 videre reaksjonstrinn fra 2,7-difluor-9-fluorenon. Production of 2,7-difluoro-4-methoxy-9-fluorenones takes place via 4 h.h.v. 5 further reaction steps from 2,7-difluoro-9-fluorenone.
Oppgaven til foreliggende oppfinnelse er å stille til rådighet en økonomisk og i stor målestokk gjennomførbar fremgangsmåte av 2,7-difluor-9-fluorenon med formel IX, som unngår de ulempene som opptrer ved fremstilling ifølge nåværende teknikk. Det betyr at det samlede utbytte er høyt, produktet er i høyere renhet og det opptrer ikke på noen kjent måte karsinogene mellomprodukter. The task of the present invention is to provide an economical and on a large scale practicable process of 2,7-difluoro-9-fluorenone of formula IX, which avoids the disadvantages that occur in production according to current technology. This means that the overall yield is high, the product is of higher purity and carcinogenic intermediates do not appear in any known way.
Denne oppgaven blir ifølge oppfinnelsen løst ved at nye bifenylkarboksylsyrer med formel I blir til rådighet, som blir overført på en enkel måte ved cyklisering til tilsvarende flurenon, hvorved denne fås i høyt utbytte. Ved fremstilling av bifenylkarboksylsyrer med formel I ifølge oppfinnelsen såvel som deres videre bearbeiding til fluorenon IX opptrer ikke de nevnte ulempene. According to the invention, this task is solved by making new biphenylcarboxylic acids of formula I available, which are transferred in a simple way by cyclization to the corresponding flurenone, whereby this is obtained in high yield. In the preparation of biphenylcarboxylic acids of formula I according to the invention as well as their further processing to fluorenone IX, the aforementioned disadvantages do not occur.
Oppfinnelsen vedrører dermed bifenylkarboksylsyrer med formel I og en fremgangsmåte for deres fremstilling. The invention thus relates to biphenylcarboxylic acids of formula I and a process for their preparation.
Fremgangsmåten for fremstilling av substituerte bifenylkarboksylsyrer med formel I er kjennetegnet ved at man The method for producing substituted biphenylcarboxylic acids of formula I is characterized by the fact that
a) omsetter en 2-metoksybenzosyre med formel IIa) reacts a 2-methoxybenzoic acid of formula II
OCH3OCH3
(ØpC02H II (EpC02H II
F F
eller et reaktivt derivat av denne syren med et etanolamin med formel III or a reactive derivative of this acid with an ethanolamine of formula III
R2R3 R2R3
I I I I
H2N -C-C-OH III H2N -C-C-OH III
R2R3 R2R3
der R<2>og R<3>betyr hydrogen eller (C1-C3)-alkyl, fortrinnsvis metyl, hvorved hver R<2>og R<3>ikke samtidig betyr alkyl, til et amid med den generelle formel IV where R<2> and R<3> represent hydrogen or (C1-C3)-alkyl, preferably methyl, whereby each R<2> and R<3> does not simultaneously represent alkyl, to an amide of the general formula IV
der R<2>og R<3>har den angitte betydning som i formel III, amidet med formel IV cykliseres deretter til en dihydro-oksazol med formel V der R<2>og R<3>har samme betydning som angitt i formel III, deretter omsettes dihydrooksazol formel V med et metallorganisk reagens med formel VI der R<*>har den angitte betydning som i formel I og M betyr litium eller Zn-Hal eller fortrinnsvis Mg-Hal og Hal betyr klor, brom eller jod, til et bifenylderivat med den generelle formel VII der R<1>har den angitte betydning som i formel I og R<2>og R<3>har betydning som angitt i formel III, at det oppnådde bifenylderivatet med formel VII eventuelt etter overføring til tilsvarende alkylerte forbindelse med formel VIII der R<1>har den angitte betydning som i formel I og R<2>og R<3>har den angitte betydning som i formel III, R<4>betyr (C1-C3)-alkyl, fortrinnsvis metyl, og X" betyr klorid, bromid, jodid, metylsulfat eller etylsulfat, blir hydrolysert til karboksylsyre med formel I where R<2> and R<3> have the indicated meaning as in formula III, the amide of formula IV is then cyclized to a dihydro-oxazole of formula V where R<2> and R<3> have the same meaning as indicated in formula III, then dihydrooxazole formula V is reacted with an organometallic reagent of formula VI where R<*> has the indicated meaning which in formula I and M means lithium or Zn-Hal or preferably Mg-Hal and Hal means chlorine, bromine or iodine, to a biphenyl derivative of the general formula VII where R<1> has the indicated meaning as in formula I and R<2> and R<3> have the meaning as indicated in formula III, that the biphenyl derivative of formula VII was obtained possibly after transfer to corresponding alkylated compound of formula VIII where R<1> has the indicated meaning as in formula I and R<2> and R<3> have the indicated meaning as in formula III, R<4> means (C1-C3)-alkyl, preferably methyl, and X" means chloride, bromide, iodide, methyl sulfate or ethyl sulfate, is hydrolyzed to the carboxylic acid of formula I
der R<*>har betydning som angitt i formel I. where R<*> has the meaning as indicated in formula I.
Bifenylkarboksylsyrer med formel I kan deretter direkte bli cyklisert på i og for seg kjente måter, over det tilsvarende syreklorid eller amidet til substituert fluorenon med formel Biphenylcarboxylic acids of formula I can then be directly cyclized in ways known per se, over the corresponding acid chloride or amide of substituted fluorenone of formula
IX. IX.
Fremgangsmåten ifølge oppfinnelsen har den fordel at den utgår fra tilsvarende substituerte utgangsmateriale og på en målrettet vei fører til rene bifenylkarboksylsyrer med formel I der posisjonen til substituentene blir fastlagt gjennom syntesen. Omstendelig og tapsbringende isomeradskillelse er ikke nødvendig og det samlede utbytte (omtrent 65$) ligger betydelig høyere enn ved den kjente fremgangsmåten (omtrent 105^). Etter fremgangsmåten ifølge oppfinnelsen må f.eks. bare to isolerte mellomtrinn bli gjennomløpt til syntese av 4,4'-difluorbifenyl-2-karboksylsyre ved å utgå fra 5-fluor-2-metoksybenzosyre (forbindelse V og VII). The method according to the invention has the advantage that it starts from correspondingly substituted starting material and in a targeted way leads to pure biphenylcarboxylic acids of formula I where the position of the substituents is determined through the synthesis. Time-consuming and loss-making isomer separation is not necessary and the overall yield (about 65$) is significantly higher than with the known method (about 105^). According to the method according to the invention, e.g. only two isolated intermediate steps are passed through for the synthesis of 4,4'-difluorobiphenyl-2-carboxylic acid by starting from 5-fluoro-2-methoxybenzoic acid (compounds V and VII).
4,4'-difluorbifenylkarboksylsyrer med formel I forekommer etter fremgangsmåten i oppfinnelsen i en meget renere form. Dette gjelder også for den derav fremstillbare fluorenon. 4,4'-difluorobiphenylcarboxylic acids of formula I occur according to the method of the invention in a much purer form. This also applies to the fluorenone that can be produced from it.
Særlig viktig er det at de kjente karsinogene nitro- og aminofluorenderivater ikke må bli gjennomløpte. It is particularly important that the known carcinogenic nitro and aminofluorene derivatives must not be run through.
Fremgangsmåten for fremstilling av benzamid IV ifølge oppfinnelsen fra benzosyre II blir gjennomført med aminoalkohol III på en i og for seg kjent måte, f.eks. gjennom-fører man omsetning med en ( C^-- C^ )-alkylester av II med aminoalkoholet III ved oppvarming av komponentene i nærvær eller fravær av et løsningsmiddel. Amidet med formel IV kan man også ved reaksjon med syre II overføre med et syreklorid, som klormaursyreester eller toluolsulfoklorid, i nærvær av en base som f.eks. trietylamin, i et egnet anhydrid, og deretter reagere med et amin med formel III til amidet IV. I en foretrukket utførelsesform av fremgangsmåten ifølge oppfinnelsen blir syren II f.eks. overført med PCI5under fortrinnsvis tionylklorid til det tilsvarende syreklorid, som i faste kvantitative utbytter med et amin III gir det tilsvarende amid IV. The process for producing benzamide IV according to the invention from benzoic acid II is carried out with amino alcohol III in a manner known per se, e.g. reaction is carried out with a (C 1 - C 2 )-alkyl ester of II with the amino alcohol III by heating the components in the presence or absence of a solvent. The amide of formula IV can also be transferred by reaction with acid II with an acid chloride, such as chloroformate or toluene sulphochloride, in the presence of a base such as e.g. triethylamine, in a suitable anhydride, and then react with an amine of formula III to give the amide IV. In a preferred embodiment of the method according to the invention, the acid II is e.g. transferred with PCI5 under preferably thionyl chloride to the corresponding acid chloride, which in fixed quantitative yields with an amine III gives the corresponding amide IV.
Cyklisering av amider med formel IV til dihydrooksazolen V kan bli gjennomført på i og for seg kjente måter med vann-bindende midler, som konsentrert svovelsyre, polyfosforsyre eller fosforpentoksid. Cyklisering med tionylklorid foregår fortrinnsvis i et egnet inert oppløsningsmiddel som f.eks. dietyleter, metylenklorid eller toluol. De kan bli gjennom-førte ved temperaturer mellom -10 og 50°C, fortrinnsvis ved 0 til 30°C. Fra det deretter oppstående hydroklorid blir det frie dihydrooksazolderivat V fremstilt med baser som f.eks. natronlut. Cyclization of amides with formula IV to the dihydrooxazole V can be carried out in ways known per se with water-binding agents, such as concentrated sulfuric acid, polyphosphoric acid or phosphorus pentoxide. Cyclization with thionyl chloride preferably takes place in a suitable inert solvent such as e.g. diethyl ether, methylene chloride or toluene. They can be carried out at temperatures between -10 and 50°C, preferably at 0 to 30°C. From the hydrochloride that then forms, the free dihydrooxazole derivative V is prepared with bases such as e.g. baking soda.
I en særlig foretrukket utførelsesform av fremgangsmåten ifølge oppfinnelsen blir dihydrooksazol V fremstilt fra benzosyre II, uten å isolere amidet med formel IV. I enkelhet blir der benzosyre II oppvarmet med et mindre overskudd tionylklorid i fravær eller nærvær av et inert oppløsnings-middel som metylenklorid eller toluol og løsningen med det oppstående syrekloridet blir dråpevis tilsatt aminoalkohol III. Da aminoalkohol også fungerer som syremottaker, blir det anvendt en dobbelt molar mengde. Et alternativ til dette er anvendelse av et mol aminoalkohol III og et mol av en inert base som trietylamin. Ved etterfølgende tilsats av den molare mengden tionylklorid i reaksjonsblandingen foregår ringslut-ningen til dihydrooksazol V. Etter alkali-Innstilling av reaksjonsblandingen med natronlut og inndamping av den organiske fasen oppnår man dihydrooksazol V i neste kvantitative utbytte. Produktet kan bli renset ved destillasjon. In a particularly preferred embodiment of the method according to the invention, dihydrooxazole V is prepared from benzoic acid II, without isolating the amide of formula IV. In simplicity, benzoic acid II is heated with a small excess of thionyl chloride in the absence or presence of an inert solvent such as methylene chloride or toluene and the solution with the resulting acid chloride is added dropwise to amino alcohol III. As amino alcohol also acts as an acid acceptor, a double molar amount is used. An alternative to this is the use of one mole of amino alcohol III and one mole of an inert base such as triethylamine. Upon subsequent addition of the molar amount of thionyl chloride in the reaction mixture, the ring closure to dihydrooxazole V takes place. After alkali adjustment of the reaction mixture with caustic soda and evaporation of the organic phase, dihydrooxazole V is obtained in the next quantitative yield. The product can be purified by distillation.
På overraskende måte forløper omsetningen av dihydrooksazol V med et metallorganisk reagens VI enhetlig under substitusjon av metoksygruppen, hvorved man oppnår bifenylderivatet med formel VII. Nevneverdige sidereaksjoner ved nukleofil utbytting f.eks. et fluoratom i forbindelse V eller VII opptrer ikke. Som løsningsmiddel for denne omsetningen kan det bli anvendt eter, som dietyleter, metyl-t-butyleter eller dibutyleter, tetrahydrofuran er foretrukket. Med magnesium-eller sinkorganiske forbindelser foregår reaksjonen ved temperaturer mellom 0°C og kokepunkttemperaturen til løs-ningsmiddelet, med 4-fluorfenyllitium lar man reaksjonen foregå mellom -60°C og romtemperatur. De metallorganiske reagensene VI blir anvendt i overskudd for å oppnå et tilfredsstillende utbytte, og nærmere bestemt 1,2 til 3,0 mol, fortrinnsvis 2-3 mol pr. mol dihydrooksazol V. Reaksjonen kan foregå i nærvær eller fravær av en katalytisk mengde palladiumforbindelse som f.eks. Pd (PPh3)4- Surprisingly, the reaction of dihydrooxazole V with an organometallic reagent VI proceeds uniformly with substitution of the methoxy group, whereby the biphenyl derivative of formula VII is obtained. Notable side reactions in nucleophilic substitution, e.g. a fluorine atom in compound V or VII does not appear. Ether can be used as a solvent for this reaction, such as diethyl ether, methyl-t-butyl ether or dibutyl ether, tetrahydrofuran is preferred. With magnesium or organic zinc compounds the reaction takes place at temperatures between 0°C and the boiling point temperature of the solvent, with 4-fluorophenyllithium the reaction is allowed to take place between -60°C and room temperature. The organometallic reagents VI are used in excess to achieve a satisfactory yield, and more specifically 1.2 to 3.0 mol, preferably 2-3 mol per mol dihydrooxazole V. The reaction can take place in the presence or absence of a catalytic amount of palladium compound such as e.g. Pd(PPh3)4-
Fortrinnsvis foregår dannelse av bifenylderivat VII fra dihydrooksazol V og Grignard-reagens VI (M = Mg Br). Dermed kan Grignard-reagenset bli gitt til dihydrooksazol eller dihydrooksazol V til Grignard-reagenset. Preferably, formation of biphenyl derivative VII takes place from dihydrooxazole V and Grignard reagent VI (M = Mg Br). Thus, the Grignard reagent can be given to dihydrooxazole or dihydrooxazole V to the Grignard reagent.
I en særlig foretrukket utførelsesform av fremgangsmåten ifølge oppfinnelsen blir f.eks. ved fremstilling av 4,4'-difluorbifenyl-2-karboksylsyre magnesium med den samlede mengden THF tilsatt og Vitride blir tilsatt (NaAlH2(0CH2CH20CH3)270# i toluol), inntil hydrogenstoffutviklingen er avsluttet. I den kokende THF lar man deretter 4-bromfluorbenzol løpe, hvorved Grignard-reaksjonen raskt forløper. Etter avsluttet dannelse av Grignard-reagenset blir dihydro-oksazol V tilsatt med eller fortrinnsvis uten løsningsmiddel. Etter kortere tid (omtrent 10 minutter) er reaksjonen avsluttet. Den blir hydrolysert med vann eller mettet ammoniumklorid-løsnlng og innstilt med saltsyre til pH 4-7, for å oppnå en god faseadskillelse. Produktet kan bli renset ved krystallisasjon og/eller destillasjon. In a particularly preferred embodiment of the method according to the invention, e.g. in the preparation of 4,4'-difluorobiphenyl-2-carboxylic acid magnesium with the total amount of THF added and Vitride is added (NaAlH2(0CH2CH20CH3)270# in toluene), until hydrogen evolution is complete. In the boiling THF, 4-bromofluorobenzene is then allowed to run, whereby the Grignard reaction proceeds rapidly. After completion of formation of the Grignard reagent, dihydro-oxazole V is added with or preferably without solvent. After a shorter time (approximately 10 minutes), the reaction is finished. It is hydrolysed with water or saturated ammonium chloride solution and adjusted with hydrochloric acid to pH 4-7, in order to achieve a good phase separation. The product can be purified by crystallization and/or distillation.
Forsåpningen av dihydro-1,3-oksazol VII til bifenylkarboksylsyre I foregår gjennom hydrolyse med vandige syrer, f.eks. ved oppvarming med saltsyre, svovelsyre eller metansulfon-syre. The saponification of dihydro-1,3-oxazole VII to biphenylcarboxylic acid I takes place through hydrolysis with aqueous acids, e.g. by heating with hydrochloric acid, sulfuric acid or methanesulfonic acid.
Ved en foretrukket variant av fremgangsmåten ifølge oppfinnelsen blir forbindelsene med generell formel VII omsatt med alkyleringsmidler som f.eks. ( C^- Cq)-alkylhalogenider, metansulfonsyre(C^-C3)alkylestere, toluolsulfonsyre(C1-C3)-alkylestere eller di(C1-C3)alkylsulfater til forbindelser med den generelle formel VIII. Særlig foretrukne som alkyleringsmidler er dimetylsulfat, metyljodid, metylbromid og metyl-klorid i løsningsmidler som toluol, aceton, 2-butanon eller laveremolekylære alkoholer. Alkyleringsreaksjonen kan gjennomføres i nærvær eller fortrinnsvis I fravær av en base som natronlut, kaliumkarbonat eller trietylamin, eventuelt også i nærvær av faseoverførings-katalysatorer som tetra-butylammoniumsulfat. Det oppstående dihydro-1,3-oksazolium-salt VIII blir deretter hydrolysert til bifenylkarboksylsyre I. Dette kan foregå ved oppvarming med vandig alkali-hydroksidoppløsning, som natronlut eller kalilut, fortrinnsvis en inndråpningsreaksjon, uten å isolere saltet VIII. In a preferred variant of the method according to the invention, the compounds of general formula VII are reacted with alkylating agents such as e.g. (C 1 -C 4 )-alkyl halides, methanesulfonic acid (C 1 -C 3 )alkyl esters, toluenesulfonic acid (C 1 -C 3 )alkyl esters or di(C 1 -C 3 )alkyl sulfates to compounds of the general formula VIII. Particularly preferred as alkylating agents are dimethyl sulphate, methyl iodide, methyl bromide and methyl chloride in solvents such as toluene, acetone, 2-butanone or lower molecular weight alcohols. The alkylation reaction can be carried out in the presence or preferably in the absence of a base such as caustic soda, potassium carbonate or triethylamine, possibly also in the presence of phase transfer catalysts such as tetra-butylammonium sulphate. The resulting dihydro-1,3-oxazolium salt VIII is then hydrolysed to biphenylcarboxylic acid I. This can take place by heating with an aqueous alkali hydroxide solution, such as caustic soda or caustic soda, preferably an opening reaction, without isolating the salt VIII.
Ringlukking av karboksylsyre I til fluorenon IX foregår på i og for seg kjent måte f.eks. med vannavspaltende midler som f.eks. i polyfosforsyre ved temperaturer mellom ca. 80-120°C. Ring closure of carboxylic acid I to fluorenone IX takes place in a manner known per se, e.g. with water-releasing agents such as e.g. in polyphosphoric acid at temperatures between approx. 80-120°C.
Forbindelsene med formlene V, VII og VIII er nye og frem-stiller verdifulle mellomprodukter til f.eks. fremstilling av bifenylkarboksylsyrer med formel I. Oppfinnelsen vedrører dermed også disse mellomproduktene og fremgangsmåtene til deres fremstilling. The compounds with the formulas V, VII and VIII are new and produce valuable intermediates for e.g. production of biphenylcarboxylic acids with formula I. The invention thus also relates to these intermediate products and the methods for their production.
Eksempel 1Example 1
4. 4'- difluorblfenvl- 2- karboksylsvre4. 4'-difluorobiphenyl-2-carboxylic acid
1) 5- f luor- 2- metoksvbenzosyre- 2-( l- hvdroksv- 2- metvl ) propyl-amid ( IV) 1) 5-fluoro-2-methoxybenzoic acid-2-(1-hydroxy-2-methyl)propyl-amide (IV)
23,0 g (0,135 mol) 5-fluor-2-metoksybenzosyre blir oppløst i 50 ml metylenklorid. Ved romtemperatur tilsetter man 17,6 ml (0,2 mol) tionylklorid og 2 dråper DMF og oppvarmer langsomt 23.0 g (0.135 mol) of 5-fluoro-2-methoxybenzoic acid are dissolved in 50 ml of methylene chloride. At room temperature, 17.6 ml (0.2 mol) thionyl chloride and 2 drops of DMF are added and heated slowly
til koking. Etter avsluttet reaksjon (tynnsjiktkontroll etter tilsats av metanol til en prøve av reaksjonsblandingen) blir det inndampet i vakuum og tionylklorid-resten blir etter to gangers tilsats av videre metylenklorid fjernet i vakuum. Resten (28,7 g) blir løst i 100 ml metylenklorid og den oppnådde løsningen ved 0-5°C blir tildråpet en løsning av 24,06 g (0,27 mol) 2-amino-2-metyl-l-propanol i 50 ml metylenklorid. Man omrører 1 time uten isavkjøling og vasker to ganger, hver gang med 100 ml vann, deretter med 50 ml fortynnet BC1, tørker over vannfri natriumsulfat og inndamper 1 vakuum. Den krystalliserte resten (30,5 g, 93,556 av teoretisk) er tilstrekkelig ren for videre omsetning. for cooking. After completion of the reaction (thin-layer control after addition of methanol to a sample of the reaction mixture) it is evaporated in vacuum and the thionyl chloride residue is removed in vacuum after twice the addition of further methylene chloride. The residue (28.7 g) is dissolved in 100 ml methylene chloride and the solution obtained at 0-5°C is added dropwise to a solution of 24.06 g (0.27 mol) 2-amino-2-methyl-1-propanol in 50 ml methylene chloride. The mixture is stirred for 1 hour without ice cooling and washed twice, each time with 100 ml of water, then with 50 ml of diluted BC1, dried over anhydrous sodium sulphate and evaporated under vacuum. The crystallized residue (30.5 g, 93.556 of theory) is sufficiently pure for further reaction.
Smp. 97 - 98"C (fra isopropanol).Temp. 97 - 98"C (from isopropanol).
1-H-NMR: S = 4,8 ppm (t, 1H), 3,95 ppm (s, 3H), 3,65 ppm 1-H-NMR: S = 4.8 ppm (t, 1H), 3.95 ppm (s, 3H), 3.65 ppm
(d, 2H), 1,4 ppm (s, 6H)(d, 2H), 1.4 ppm (s, 6H)
2 ) 2-( 5- f luor- 2- oretoksvf envl )- 4 . 4- d ime tvi- 4 . 5- dihvdro- l. 3-oksazol ( V) a) Til 14,4 ml (0,17 mol) tionylklorid tilsetter man ved 20-250 C porsjonsvls 20 g (0,083 mol) 5-fluor-2-metoksy-benzosyre-2-(l-hydroksy-2-metyl)-propylamid, hvorved man fra tid til annen må avkjøle med isvann. Det blir etterrørt en time ved romtemperatur, deretter blir det to ganger tilsatt 100 ml eter, omrørt og deretter blir eterfasen dekantert vekk. Den halvkrystallinske resten blir tatt ut i 100 ml metylenklorid. Løsningen tildråper man under isavkjøling ved omtrent 15° C til 150 ml halvkonsentrert natronlut. På slutten av til-dråpingen må pH-verdien til den vandige fasen ligge over 10. Den vandige fasen blir fraskilt og enda en gang ekstrahert med metylenklorid. De forenede organiske fasene blir vasket med mettet natriumklorid-løsning, tørket over vannfri natriumsulfat og inndampet i vakuum. Man får 18,7 g av en olje som litt etter litt krystalliserer. Etter destillasjon smelter produktet ved 35 - 36°C. Kokepunktø^ 98"C. 2 ) 2-( 5-fluoro- 2- orethoxvf envl )- 4 . 4- d ime tvi- 4 . 5-dihydro-l. 3-oxazole (V) a) To 14.4 ml (0.17 mol) of thionyl chloride, 20 g (0.083 mol) of 5-fluoro-2-methoxy-benzoic acid are added at 20-250 C portionwise 2-(1-Hydroxy-2-methyl)-propylamide, which requires cooling with ice water from time to time. It is stirred for one hour at room temperature, then 100 ml of ether is added twice, stirred and then the ether phase is decanted away. The semi-crystalline residue is taken up in 100 ml of methylene chloride. The solution is added dropwise under ice-cooling at approximately 15° C to 150 ml of semi-concentrated caustic soda. At the end of the dropwise addition, the pH value of the aqueous phase must be above 10. The aqueous phase is separated and once more extracted with methylene chloride. The combined organic phases are washed with saturated sodium chloride solution, dried over anhydrous sodium sulfate and evaporated in vacuo. You get 18.7 g of an oil which little by little crystallizes. After distillation, the product melts at 35 - 36°C. Boiling point ø 98"C.
Utbytte: Råprodukt 93 -10056, etter destillasjon 85 - 9556. Yield: Raw product 93 -10056, after distillation 85 - 9556.
<*>H-HMR: S - 6,6-7,6 ppm (m, 3H), 4,05 ppm (s, 2H), 3,8 ppm (s, 3H), 1,35 ppm (s, 6H). <*>H-HMR: S - 6.6-7.6 ppm (m, 3H), 4.05 ppm (s, 2H), 3.8 ppm (s, 3H), 1.35 ppm (s, 6H).
b) (Inndråpingsreaksjon)b) (Instillation reaction)
230 g 5-fluor-2-metoksybenzosyre blir oppløst i 100 ml 230 g of 5-fluoro-2-methoxybenzoic acid are dissolved in 100 ml
metylenklorid og 1 ml DMF. Til dette tilsetter man 108 ml tionylklorid. Man oppvarmer under tilbakekjøling inntil syreklorid-dannelsen er utelukket (omtrent 1 time). Til den klare reaksjonsløsningen lar man deretter tilløpe ved ICC en løsning av 293,5 ml 2-amino-2-metyl-l-propanol i 200 ml metylenklorid. Etter avsluttet tilsetning blir det etterrørt i 30 minutter ved romtemperatur, og deretter blir 98 ml tionylklorid tildråpet ved 20°C. Det blir etterrørt i 15 minutter og det blir tildråpet omtrent 250 ml konsentrert natronlut til det oppnås en pH-verdi på >10. Den organiske fasen blir vasket en gang med fortynnet natronlut, tørket over natriumsulfat og destillert i vakuum. methylene chloride and 1 ml DMF. To this is added 108 ml of thionyl chloride. It is heated under reflux until the formation of acid chloride is excluded (approximately 1 hour). A solution of 293.5 ml of 2-amino-2-methyl-1-propanol in 200 ml of methylene chloride is then added to the clear reaction solution at ICC. After the addition has been completed, it is stirred for 30 minutes at room temperature, and then 98 ml of thionyl chloride is added dropwise at 20°C. It is stirred for 15 minutes and approximately 250 ml of concentrated caustic soda is added drop by drop until a pH value of >10 is achieved. The organic phase is washed once with dilute caustic soda, dried over sodium sulfate and distilled in vacuo.
Utbytte 276 g (92 ,956).Yield 276 g (92 .956).
3) 2-( 4 . 4 '- difluorbifenvl- 2- vl)- 4. 4- dimetvl- 4. 5- dihvdro- l. 3-oksazol VII 3) 2-(4.4'-difluorobiphenyl-2-yl)-4.4-dimethyl-4.5-dihydro-1.3-oxazole VII
1,18 kg magnesiumspon blir tilsatt i 25 1 THF og oppvarmet til 50-60°C. Det blir tilsatt Vitride-løsning i toluol (7056) inntil hydrogenutviklingen er avsluttet (omtrent 150 ml). Man oppvarmer blandingen under tilbakekjøling og tilsetter ved kraftig omrøring 500 g 4-bromfluorbenzol. Den eksoterme reaksjonen starter nesten øyeblikkelig. Man tilsetter videre 7,99 kg 4-bromfluorbenzol ved at blandingen fremdeles blir kokt på tilbakekjøling. Etter avsluttet tilsats blir den oppvarmet videre i 1 time. Deretter blir 3,6 kg 2-(5-fluor-2-metoksyfenyl)-4,4-dimetyl-4,5-dihydro-l,3-oksazol 15 1 tørket THF ved romtemperatur tilsatt og oppvarmet videre i 15 minutter. Blandingen blir avkjølt til 10°C. Ved 10-2CC blir 20 1 mettet ammoniumklorid-løsning tilsatt under god av-kjøling og innstilt med omtrent 3,5 1 konsentrert saltsyre til pH-verdi 6. Det utfellende saltet ble løst med vann og 1.18 kg of magnesium shavings are added to 25 1 THF and heated to 50-60°C. Vitride solution in toluene (7056) is added until hydrogen evolution has ended (approximately 150 ml). The mixture is heated while cooling and, with vigorous stirring, 500 g of 4-bromofluorobenzene is added. The exothermic reaction starts almost immediately. 7.99 kg of 4-bromofluorobenzene is further added, while the mixture is still boiled on reflux. After the addition has been completed, it is heated further for 1 hour. Then 3.6 kg of 2-(5-fluoro-2-methoxyphenyl)-4,4-dimethyl-4,5-dihydro-1,3-oxazole 15 1 dried THF at room temperature are added and heated further for 15 minutes. The mixture is cooled to 10°C. At 10-2 CC, 20 1 of saturated ammonium chloride solution is added with good cooling and adjusted with approximately 3.5 1 of concentrated hydrochloric acid to a pH value of 6. The precipitated salt was dissolved with water and
fasene adskilt. Den organiske fasen blir vasket med 9 1 mettet natriumklorid-løsning, omrørt med 200 g aktivt kull, tørket med natriumsulfat og suget vekk. Etter inndamping av løsningsmiddelet og tørking i vakuum fikk man 4,5 kg av et gult, krystallinsk produkt, som er tilstrekkelig rent for videre omsetning (9756 etter GC-analyse, utbytte 94 ,256). Det kan bli renset ved krystallisering fra isopropanol eller diisopropyleter og destillasjon av den opprinnelige luten med tynnsj iktfordamper. the phases separated. The organic phase is washed with 9 1 of saturated sodium chloride solution, stirred with 200 g of activated charcoal, dried with sodium sulfate and sucked away. After evaporation of the solvent and drying in vacuum, 4.5 kg of a yellow, crystalline product was obtained, which is sufficiently pure for further processing (9756 after GC analysis, yield 94.256). It can be purified by crystallization from isopropanol or diisopropyl ether and distillation of the original liquor with a thin-layer evaporator.
Kokepunkt 126 - 130"C (0,1 mm)Boiling point 126 - 130"C (0.1 mm)
Frysepunkt 83 - 84°CFreezing point 83 - 84°C
<1->H-NMR: S - 6,4-7,5 ppm (m, 7H), 3,85 ppm (s, 2H), 1,28 <1->H-NMR: S - 6.4-7.5 ppm (m, 7H), 3.85 ppm (s, 2H), 1.28
ppm (s, 6H)ppm (s, 6H)
4. a) 2-( 4 . 4 ' - difluorblfenvl- 2- vl)- 3. 4. 4- tr imetvi- 4. 5-dihvdro- 1. 3- oksazolium- riodid ( VIII. E, R-2-. R-i - 4. a) 2-( 4 . 4 ' - difluoroblphenvl- 2- vl)- 3. 4. 4- tri imetvi- 4. 5- dihydro- 1. 3- oxazolium- riodide (VIII. E, R-2- .R-i -
CH3. RÅ°H. X - ji^i)CH3. RAW°H. X - ji^i)
8,6 g 2-(4,4'-difluorbifenyl-2-yl)-4,4-dimetyl-4,5-dihydro-1,3-oksazol blir omrørt i 60 ml aceton og 30 ml metyljodid i 2 dager under tilbakekjøling. Man inndamper i vakuum og krystalliserer den oljeaktige resten ved tilsats av litt aceton. Etter avsuging og vasking med litt aceton fikk man 5,8 g krystaller med frysepunkt 179°C. 8.6 g of 2-(4,4'-difluorobiphenyl-2-yl)-4,4-dimethyl-4,5-dihydro-1,3-oxazole are stirred in 60 ml of acetone and 30 ml of methyl iodide for 2 days under cooling back. Evaporate in a vacuum and crystallize the oily residue by adding a little acetone. After suction and washing with a little acetone, 5.8 g of crystals with a freezing point of 179°C were obtained.
<1->H-NMR: 5 - 8,3 - 8,6 (m, IB), 7,1 - 7,6 (m, 6H), 5,25 <1->H-NMR: 5 - 8.3 - 8.6 (m, IB), 7.1 - 7.6 (m, 6H), 5.25
(s, 2H), 2,85 (s, 3H), 1,6 (s, 6H). (s, 2H), 2.85 (s, 3H), 1.6 (s, 6H).
b) 2-( 4 . 4 '- dif luorbifenvl- 2- vl )- 3. 4 . 4- trimetvl- 4 , 5- dlhvdro-1. 3- oksazollum- metvlsulfat ( VIII. Ri - ° H. R^. R4- - CH3. R3-- H. X ° SO^) b) 2-( 4 . 4 '- difluorbifenvl- 2- vl )- 3. 4 . 4- trimetvl- 4 , 5- dlhvdro-1. 3- oxazolum- metvlsulphate (VIII. Ri - ° H. R^. R4- - CH3. R3-- H. X ° SO^)
4,3 g av dihydro-oksazol (fra 3.) blir omrørt i 30 ml toluol og 1,71 ml dimetylsulfat i to timer under tilbakekjøling. Saltet krystalliseres ut over natten. Man suger vekk, vasker med litt aceton og får 5,65 g (92 ,656) av produktet. Det er tilstrekkelig rent for videre omsetning. Etter omkrystal-lisering fra isopropanol smelter det ved 167 - 169"C. 4.3 g of dihydro-oxazole (from 3.) is stirred in 30 ml of toluene and 1.71 ml of dimethylsulphate for two hours under reflux. The salt crystallizes out overnight. One sucks away, washes with a little acetone and gets 5.65 g (92 .656) of the product. It is sufficiently clean for further sales. After recrystallization from isopropanol it melts at 167 - 169°C.
<i>H-NMR: S - 8,05 - 8,35 (m, 1H), 7,0 - 7,6 (m, 6H), 5,05 <i>H-NMR: S - 8.05 - 8.35 (m, 1H), 7.0 - 7.6 (m, 6H), 5.05
(s, 2H), 3,7 (s, 3H), 2,75 (s, 3H), 1,5 (s, 6H). (s, 2H), 3.7 (s, 3H), 2.75 (s, 3H), 1.5 (s, 6H).
5. 4. 4'- difluorbifenyl- 2- karboksylsyre ( I)5. 4. 4'- difluorobiphenyl- 2- carboxylic acid ( I)
a) 7,18 g 2-(4,4 *-difluorbifenyl-2-yl)-4,4*-dimetyl-4,5-dihydro-1,3-oksazol (forbindelse VII) blir forsåpet i a) 7.18 g of 2-(4,4*-difluorobiphenyl-2-yl)-4,4*-dimethyl-4,5-dihydro-1,3-oxazole (compound VII) is saponified in
75 ml dioksan og 80 ml halvkonsentrert saltsyre i 3 dager 75 ml of dioxane and 80 ml of semi-concentrated hydrochloric acid for 3 days
under tilbakekjøling. Løsningsmiddelet blir fjernet i vakuum, resten blir tatt ut i litt halvkonsentrert natronlut, løsningen blir vasket to ganger med 50 ml eter hver gang, klargjort med aktiv kull og surgjort med fortynnet saltsyre. Man suger vekk og vasker med vann. Man får fargeløse krystaller med frysepunkt 117 - 119'C. Etter omkrystalllsering fra isopropanol/vann smelter produktet ved 124'C. Utbytte 6156. b) I en løsning med 1,6 g NaOH i 30 ml vann tilsetter man 4,0 g 2-(4,4'-difluorbifenyl-2-yl)-3,4,4-trimetyl-4,5-dihydro-1,3-oksazolium-metylsulfat (forbindelse VIII) og 30 ml metanol. Etter 2 timer ved 65°C blir reaksjons-løsningen surgjort med 2 N HC1 og Inndampet i vakuum. Resten blir omkrystallisert i isopropanol/EtøO 1:4 og tørket. during recooling. The solvent is removed in vacuo, the residue is taken out in a little semi-concentrated caustic soda, the solution is washed twice with 50 ml of ether each time, clarified with activated charcoal and acidified with dilute hydrochloric acid. One vacuums away and washes with water. Colorless crystals with a freezing point of 117 - 119'C are obtained. After recrystallization from isopropanol/water, the product melts at 124°C. Yield 6156. b) In a solution with 1.6 g of NaOH in 30 ml of water, 4.0 g of 2-(4,4'-difluorobiphenyl-2-yl)-3,4,4-trimethyl-4,5 -dihydro-1,3-oxazolium methyl sulfate (compound VIII) and 30 ml of methanol. After 2 hours at 65°C, the reaction solution is acidified with 2 N HCl and evaporated in vacuo. The residue is recrystallized in isopropanol/EthoO 1:4 and dried.
Utbytte: 2,25 g ( 99%) med frysepunkt 124°C.Yield: 2.25 g (99%) with freezing point 124°C.
c) På analog måte blir det fra tilsvarende jodid VIII (fra 4.a)) utvunnet karboksylsyre I etter omkrystalllsering i c) In an analogous way, carboxylic acid I is extracted from the corresponding iodide VIII (from 4.a)) after recrystallization in
et utbytte på 92, 8%.a yield of 92.8%.
d) Inndråpingsreaksjon:d) Instillation reaction:
100 g (0,348 mol) 2-(4,4'-difluorbifenyl-2-yl)-4,4-dimetyl-4,5-dihydro-l,3-oksazol (forbindelse VII) blir oppvarmet i 100 ml aceton med 40 ml (0,417 mol) dimetylsulfat i 1,5 timer under tilbakekjøling. Under reaksjonen utfelles et fargeløst bunnfall. Suspensjonen tildråpes deretter 342 ml (1,54 mol) 1856 natronlut og samtidig destilleres acetonet av. Ved en innetemperatur på 90°C blir det deretter oppvarmet under tilbakekjøling, inntil forsåpningen er avsluttet (omtrent 1 time). Man avkjøler til 20'C, hvorved reaksjonsblandingen adskilles i to faser. Den nederste fasen blir kastet, og den øvre fasen blir vasket to ganger med 100 ml toluol hver gang og deretter klargjort med aktiv kull. Under avkjøling blir det surgjort med konsentrert saltsyre, hvorved den krystallinske, fargeløse 4,4'-difluorbifenyl-2-karboksylsyre felles ut. Den blir suget av, vasket med vann og tørket i vakuum ved 30°C. 100 g (0.348 mol) of 2-(4,4'-difluorobiphenyl-2-yl)-4,4-dimethyl-4,5-dihydro-1,3-oxazole (compound VII) is heated in 100 ml of acetone with 40 ml (0.417 mol) of dimethyl sulfate for 1.5 hours under reflux. During the reaction, a colorless precipitate is precipitated. The suspension is then added dropwise to 342 ml (1.54 mol) of 1856 caustic soda and at the same time the acetone is distilled off. At an internal temperature of 90°C, it is then heated while recooling, until the saponification is finished (approximately 1 hour). It is cooled to 20°C, whereby the reaction mixture is separated into two phases. The lower phase is discarded and the upper phase is washed twice with 100 ml of toluene each time and then clarified with activated charcoal. During cooling, it is acidified with concentrated hydrochloric acid, whereby the crystalline, colorless 4,4'-difluorobiphenyl-2-carboxylic acid precipitates out. It is sucked off, washed with water and dried in a vacuum at 30°C.
Utbytte 70,1 g (86,056).Yield 70.1 g (86.056).
Den oppnådde karboksylsyren ifølge eksempel I kan bli cyklisert som følgende til 2,7-difluor-9-fluorenon (IX): 2,34 g 4,4'-difluorbifenyl-2-karboksylsyre blir tilsatt 35 g polyfosforsyre ved 40 - 50"C. Under omrøring oppvarmer man 1 time ved 100°C. Den gule suspensjonen tømmes deretter i 150 ml isvann. Det gule bunnfallet blir suget vekk og vasket grundig med vann. The carboxylic acid obtained according to example I can be cyclized as follows to 2,7-difluoro-9-fluorenone (IX): 2.34 g of 4,4'-difluorobiphenyl-2-carboxylic acid is added to 35 g of polyphosphoric acid at 40 - 50"C While stirring, heat for 1 hour at 100° C. The yellow suspension is then poured into 150 ml of ice water. The yellow precipitate is sucked off and washed thoroughly with water.
Utbytte: 2,11 g (9856) forbindelse IXYield: 2.11 g (9856) of compound IX
Frysepunkt 208 - 210°C. Freezing point 208 - 210°C.
Claims (4)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3914227A DE3914227A1 (en) | 1989-04-29 | 1989-04-29 | METHOD FOR PRODUCING 2,7-DIFLUOR-9-FLUORENONE AND NEW INTERMEDIATE PRODUCTS |
Publications (2)
Publication Number | Publication Date |
---|---|
NO901894D0 NO901894D0 (en) | 1990-04-27 |
NO901894L true NO901894L (en) | 1990-10-30 |
Family
ID=6379764
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO90901894A NO901894L (en) | 1989-04-29 | 1990-04-27 | PROCEDURE FOR THE PREPARATION OF SUBSTITUTED BIFENYL CARBOXYL ACIDS AND NEW INTERMEDIATES. |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0396014A2 (en) |
JP (1) | JPH02295946A (en) |
KR (1) | KR900016085A (en) |
AU (1) | AU5390590A (en) |
CA (1) | CA2015578A1 (en) |
DE (1) | DE3914227A1 (en) |
FI (1) | FI902111A0 (en) |
HU (1) | HUT53584A (en) |
NO (1) | NO901894L (en) |
PT (1) | PT93914A (en) |
ZA (1) | ZA903224B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5210206A (en) * | 1990-09-10 | 1993-05-11 | Abbott Laboratories | 1,3-oxazolyl substituted biphenyl |
US5391817A (en) * | 1993-12-21 | 1995-02-21 | Bristol-Myers Squibb | Biaryl phospholipase A2 inhibitors |
EP2536682A1 (en) * | 2010-02-19 | 2012-12-26 | Centre National De La Recherche Scientifique | Method for preparing chemical compounds of interest by nucleophilic aromatic substitution of aromatic carboxylic acid derivatives supporting at least one electro-attractive group |
-
1989
- 1989-04-29 DE DE3914227A patent/DE3914227A1/en not_active Withdrawn
-
1990
- 1990-04-26 HU HU902579A patent/HUT53584A/en unknown
- 1990-04-26 EP EP90107910A patent/EP0396014A2/en not_active Withdrawn
- 1990-04-26 FI FI902111A patent/FI902111A0/en not_active Application Discontinuation
- 1990-04-27 CA CA002015578A patent/CA2015578A1/en not_active Abandoned
- 1990-04-27 JP JP2110713A patent/JPH02295946A/en active Pending
- 1990-04-27 ZA ZA903224A patent/ZA903224B/en unknown
- 1990-04-27 NO NO90901894A patent/NO901894L/en unknown
- 1990-04-27 PT PT93914A patent/PT93914A/en not_active Application Discontinuation
- 1990-04-27 AU AU53905/90A patent/AU5390590A/en not_active Abandoned
- 1990-04-27 KR KR1019900005960A patent/KR900016085A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
HUT53584A (en) | 1990-11-28 |
EP0396014A2 (en) | 1990-11-07 |
PT93914A (en) | 1990-11-20 |
AU5390590A (en) | 1990-11-01 |
NO901894D0 (en) | 1990-04-27 |
ZA903224B (en) | 1991-01-30 |
FI902111A0 (en) | 1990-04-26 |
HU902579D0 (en) | 1990-08-28 |
KR900016085A (en) | 1990-11-12 |
DE3914227A1 (en) | 1991-01-10 |
JPH02295946A (en) | 1990-12-06 |
CA2015578A1 (en) | 1990-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20151744L (en) | Methods for preparing aminothiazole derivatives and intermediates for their preparation | |
NO163403B (en) | TRISUBSTITUTED BENZOIC ACID INTERMEDIATES. | |
RU2523793C2 (en) | Method of producing [4-(2-chloro-4-methoxy-5- methylphenyl)-5-methylthiazolo-2-yl] [2-cyclopropyl-1-(3- fluoro-4-methylphenyl)-ethyl]-amine | |
JP5700910B2 (en) | Process for the preparation of substituted anisidines | |
DK149230B (en) | METHOD OF ANALOGUE FOR THE PREPARATION OF 5-BENZOYL-6-HYDROXY-INDANE-1-CARBOXYLIC ACID DERIVATIVES OR PHARMACEUTICAL ACCEPTABLE SALTS THEREOF | |
NO178396B (en) | Improved process for the preparation of substituted indolone derivatives and intermediates in the preparation thereof | |
US4978773A (en) | Process for the preparation of 2,6-dichlorodiphenylaminoacetic acid derivatives | |
NO901894L (en) | PROCEDURE FOR THE PREPARATION OF SUBSTITUTED BIFENYL CARBOXYL ACIDS AND NEW INTERMEDIATES. | |
NO166712B (en) | PROCEDURE FOR THE PREPARATION OF PYRROLIDO DERIVATIVES. | |
KR20080036112A (en) | Processes for preparing pyrazole-o-glycoside derivatives and novel intermediates of said processes | |
EP1440970B1 (en) | Benzenesulfonic acid salt of 1-(6-halogeno-2-benzothiazolyl)ethylamine | |
US20060217565A1 (en) | Process for producing chromone compound | |
JP2000327603A (en) | Production of propionic acid derivative | |
JPH0597840A (en) | Production of 3-acylamino-6-phenyloxy-7-alkyl sulfonylamino-4h-1-benzopyran-4-one or its salt | |
HU194857B (en) | Process for production of 4-amin-6-fluor-cromane-4-carbonic acid and its 2/r/ methilesther | |
US5142091A (en) | α, β-unsaturated ketones and ketoxime derivatives | |
US4701528A (en) | Intermediates useful in the preparation of 3,4-dihydro-4-oxothieno[2,3-d]pyrimidine-2-carboxylates and process for preparing same | |
JP4172931B2 (en) | Process for producing 1-alkyl-5-hydroxypyrazole | |
JP4398636B2 (en) | Process for producing N- [3- (acylamino) -4-oxo-6-phenoxy-4H-chromen-7-yl] alkylsulfonamide derivatives or salts thereof and intermediates thereof | |
KR0142140B1 (en) | Method of preparation for 2-benzoyl-3-aminoacrylate derivatives | |
KR880002290B1 (en) | Process for preparing of n-(2(2-amino-2-phenylethyl)phenyl)-2,2-dimethyl propanamid | |
SU534183A3 (en) | Method for preparing benzocycloheptaoxazolone derivatives | |
JP2711435B2 (en) | Novel 2,3-dihydro-4H-1-benzopyran-4-one derivative or salt thereof | |
JP4356917B2 (en) | Process for producing bisaminomethyl-1,4-dithianes and intermediates thereof | |
KR100494880B1 (en) | A process for preparing Ethyl 2,3,5-trifluoro-4-(4-methyl-1-piperazinyl)benzoylacetate |